
Please try another search
On the 21st of September, Orbimed Advisors sold 2.1 million 89bio, Inc. (NASDAQ:ETNB) shares for $53 million at an average price of $25.00 per share. Shares of 89bio, Inc. are down -2.64% since the transaction.
Orbimed Advisors's holding in 89bio, Inc. decreased to about 1.9 million shares with the transaction.
Orbimed Advisors first bought 89bio, Inc. stock in the fourth quarter of 2019. Orbimed Advisors also owns Alexion Pharmaceuticals Inc (NASDAQ:ALXN), Biogen Inc (NASDAQ:BIIB), Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) and Neurocrine Biosciences Inc (NASDAQ:NBIX). 89bio, Inc. is its number thirteen position by number of shares and market value among pharmaceuticals stocks.
In contrast, Millennium Management and Point72 Asset Management introduced ETNB shares to their portfolio.
Orbimed Advisors has also recently reduced their share in ESSA Pharma Inc . (NASDAQ:EPIX).
Orbimed Advisors also reduced their share in Alector, Inc. (NASDAQ:ALEC). The total value of the shares sold is estimated at around $105 million.
Additionally, Orbimed Advisors established new holdings in Fusion Pharmaceuticals Inc. (FUSN). Orbimed Advisors also added to their share in Alpine Immune Sciences, Inc. (NASDAQ:ALPN), Adicet Bio, Inc. (ACET) and TELA Bio, Inc. (NASDAQ:TELA). The total value of the shares bought is estimated at around $131 million.
By Senad Karaahmetovic Citi is growing increasingly cautious about U.S. stocks after the S&P 500 rallied to exceed the bank’s 4200 year-end targets. The magnitude of the ongoing...
By Sheila Dang (Reuters) - TikTok will work to prevent content creators from posting paid political messages on the short-form video app, as part of its preparation for the U.S....
By Ludwig Burger and Tassilo Hummel (Reuters) -Sanofi stopped further work on amcenestrant, once seen to have large potential against breast cancer, after a second trial failure...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.